📰 Vstm News
Page 3 - Vstm News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vstm. Real-time updates on events, politics, business and more.
June 18, 2023
Mizuho upgraded shares of Verastem (NASDAQ:VSTM – Get Rating) from a neutral rating to a buy rating in a research report released on Thursday, The Fly reports. Mizuho currently has $36.00 price target on the biopharmaceutical company’s stock, up from their prior price target of $24.00. VSTM has been the topic of a number of […]
June 15, 2023
By Dean Seal Shares of Verastem are trading higher after the company's recent update on its ovarian cancer treatment turned Mizuho analysts bullish on the...
June 15, 2023
By Stephen Nakrosis Shares of Verastem were trading lower in Thursday's after-hours market following news the company plans to sell shares and pre-funded...
June 2, 2023
StockNews.com initiated coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. Cantor Fitzgerald restated an overweight rating on shares of Verastem in a research note on […]
May 24, 2023
StockNews.com assumed coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. VSTM has been the subject of a number of other reports. HC Wainwright decreased their price objective on Verastem from $3.00 to $2.00 in a report […]
May 22, 2023
Verastem, Inc. (NASDAQ:VSTM – Get Rating) has been given a consensus rating of “Moderate Buy” by the seven brokerages that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price objective among […]
May 19, 2023
Cantor Fitzgerald reissued their overweight rating on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Monday, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Verastem’s FY2023 earnings at ($0.26) EPS. A number of other equities analysts have also weighed in on the company. StockNews.com initiated coverage on Verastem […]
April 30, 2023
Verastem, Inc. (NASDAQ:VSTM – Get Rating) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 1,080,000 shares, a decline of 15.0% from the March 31st total of 1,270,000 shares. Based on an average daily volume of 687,500 shares, the short-interest ratio is presently 1.6 days. Verastem […]
April 30, 2023
StockNews.com assumed coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. VSTM has been the subject of a number of other research reports. Mizuho started coverage on Verastem in a report on Wednesday, March 29th. They […]
April 27, 2023
Shares of Verastem, Inc. (NASDAQ:VSTM – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average […]